Trial intelligence / Profile preview

Extremely Low Gestational Age Infants' Paracetamol Study

2018-000566-11Phase 2Completed

Sponsor
University of Oulu
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of acetaminophen in patent ductus arteriosus (PDA), sponsored by University of Oulu. Primary endpoint: Shortening of the ductal closure time. Started Apr 2018; status: completed.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on 2018-000566-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000566-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call